Jim Walsh
About Jim Walsh
Jim Walsh is a Senior Drug Safety Specialist at Alkermes and Manager of Pharmacovigilance Operations at ImmunoGen, Inc. with over twelve years of experience in pharmacovigilance and regulatory affairs.
Current Positions
Jim Walsh currently holds multiple significant roles in the pharmacovigilance sector. He works at ImmunoGen, Inc. as Manager, Pharmacovigilance Operations in Waltham, Massachusetts, having started on March 1, 2022. Additionally, he serves as a Senior Drug Safety Specialist at Alkermes, contributing his extensive experience and expertise in drug safety.
Previous Experience
Jim Walsh has a rich background in pharmacovigilance and drug safety, with experience spanning over a decade. He worked at Vertex Pharmaceuticals as Quality Lead, Pharmacovigilance from 2011 to 2012 in Cambridge, MA. Prior to that, he spent 8 years at BiogenIdec from 2003 to 2011, where he held roles such as Drug Safety Data Specialist and Clinical Trials Safety Quality Specialist.
Education and Expertise
Jim Walsh pursued his higher education at UMass Boston, where he studied Exercise Physiology and achieved a BS degree from 1992 to 1995. He has over twelve years of experience in pharmacovigilance, regulatory intelligence, regulatory reporting, quality assurance, and safety database management. His education and professional background have equipped him with outstanding writing and editing abilities, complemented by excellent communication and team skills.
Role at ImmunoGen, Inc.
Since March 1, 2022, Jim Walsh has been working as Manager, Pharmacovigilance Operations at ImmunoGen, Inc. in Waltham, Massachusetts. In this role, he is responsible for overseeing pharmacovigilance activities, ensuring regulatory compliance, and managing safety database operations.
Role at Alkermes
In addition to his responsibilities at ImmunoGen, Inc., Jim Walsh holds the position of Senior Drug Safety Specialist at Alkermes. His role involves the continuous monitoring and reporting of drug safety data, contributing to the development of safer pharmaceutical products.